Low-dose naltrexone / working resource

Study reading worksheet

Separate a reported result from the question the study was designed to answer.

Start with the product-specific question

What off-label means

Low-dose naltrexone, an off-label use, with the evidence and its limits in plain view. What should I know about what off-label use means?

A randomised, double-blind, placebo-controlled trial of 6 mg low-dose naltrexone in 99 women with fibromyalgia concluded that the study did not show treatment with low-dose naltrexone was superior to placebo in relieving pain.
Read the original record ↗

Open the Low-dose naltrexone library ↗

Write the question before the result.

A Low-dose naltrexone headline may describe an animal experiment, an uncontrolled observation or a randomized human trial. Those designs answer different questions. Complete the record before deciding whether a result applies to a product.

Document title and original URLExact molecule, formulation and route studiedStudy design and number of participants or samplesPopulation, condition and inclusion criteriaComparison or control groupPrimary endpoint and follow-up period

Keep the result attached to its boundary.

Actual result, units and uncertainty intervalWhich analysis or estimand produced this number?Was this the primary endpoint or a subgroup finding?Adverse events and missing or incomplete follow-upFunding, conflicts, correction or later publicationWhat does this study leave unanswered for this product?

When there is no human comparison group or no relevant clinical endpoint, record that explicitly. A mechanism, biomarker or plausible explanation does not become a demonstrated patient benefit.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗